Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)

South Korea flag South Korea · Delayed Price · Currency is KRW
29,400
-50 (-0.17%)
At close: Mar 6, 2026
14.84%
Market Cap 172.87B
Revenue (ttm) 209.00B
Net Income (ttm) 31.56B
Shares Out 5.88M
EPS (ttm) 5,366.74
PE Ratio 5.48
Forward PE 5.68
Dividend 900.00 (3.06%)
Ex-Dividend Date Dec 29, 2025
Volume 7,435
Average Volume 23,016
Open 29,300
Previous Close 29,450
Day's Range 29,100 - 29,600
52-Week Range 24,750 - 33,950
Beta 0.19
RSI 48.26
Earnings Date Mar 18, 2026

About Daihan Pharmaceutical

Daihan Pharmaceutical Co.,Ltd. engages in the manufacture and sale of therapeutic drugs in South Korea. The company offers various drugs, such as prescription, OTC, and quasi drugs, as well as offers various infusion related solutions. Daihan Pharmaceutical Co.,Ltd. was founded in 1945 and is headquartered in Seoul, South Korea. [Read more]

Sector Healthcare
Founded 1945
Employees 553
Stock Exchange KOSDAQ
Ticker Symbol 023910
Full Company Profile

Financial Performance

In 2024, Daihan Pharmaceutical's revenue was 204.19 billion, an increase of 4.23% compared to the previous year's 195.91 billion. Earnings were 33.76 billion, an increase of 18.76%.

Financial Statements

News

There is no news available yet.